397 related articles for article (PubMed ID: 30572158)
1. Mesoporous silica nanoparticles carrying multiple antibiotics provide enhanced synergistic effect and improved biocompatibility.
Gounani Z; Asadollahi MA; Pedersen JN; Lyngsø J; Skov Pedersen J; Arpanaei A; Meyer RL
Colloids Surf B Biointerfaces; 2019 Mar; 175():498-508. PubMed ID: 30572158
[TBL] [Abstract][Full Text] [Related]
2. Loading of polymyxin B onto anionic mesoporous silica nanoparticles retains antibacterial activity and enhances biocompatibility.
Gounani Z; Asadollahi MA; Meyer RL; Arpanaei A
Int J Pharm; 2018 Feb; 537(1-2):148-161. PubMed ID: 29278732
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin Loaded Amino-Functionalized MCM-48 Mesoporous Silica Nanoparticles as a Promising Drug Carrier in Bone Substitutes for Bacterial Infection Management.
Rahaman SN; Pathmanapan S; Sidharthan A; Anandasadagopan SK
Appl Biochem Biotechnol; 2023 Nov; 195(11):6607-6632. PubMed ID: 36892681
[TBL] [Abstract][Full Text] [Related]
4. Biocompatibility, cytotoxicity and antibacterial effects of meropenem-loaded mesoporous silica nanoparticles against carbapenem-resistant
Memar MY; Yekani M; Ghanbari H; Shahi S; Sharifi S; Maleki Dizaj S
Artif Cells Nanomed Biotechnol; 2020 Nov; 48(1):1354-1361. PubMed ID: 33236938
[TBL] [Abstract][Full Text] [Related]
5. Mesoporous silica nanoparticles decorated with polycationic dendrimers for infection treatment.
González B; Colilla M; Díez J; Pedraza D; Guembe M; Izquierdo-Barba I; Vallet-Regí M
Acta Biomater; 2018 Mar; 68():261-271. PubMed ID: 29307796
[TBL] [Abstract][Full Text] [Related]
6. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
Li Z; Zhang Y; Feng N
Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin-modified mesoporous silica nanoparticles for selective recognition and killing of pathogenic gram-positive bacteria over macrophage-like cells.
Qi G; Li L; Yu F; Wang H
ACS Appl Mater Interfaces; 2013 Nov; 5(21):10874-81. PubMed ID: 24131516
[TBL] [Abstract][Full Text] [Related]
8. Mesoporous silica nanoparticles as carrier to overcome bacterial drug resistant barriers.
Zhuang J; Yu Y; Lu R
Int J Pharm; 2023 Jan; 631():122529. PubMed ID: 36563796
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial and biofilm-inhibitory effects of vancomycin-loaded mesoporous silica nanoparticles on methicillin-resistant staphylococcus aureus and gram-negative bacteria.
Memar MY; Yekani M; Farajnia S; Ghadiri Moghaddam F; Nabizadeh E; Sharifi S; Maleki Dizaj S
Arch Microbiol; 2023 Mar; 205(4):109. PubMed ID: 36884153
[TBL] [Abstract][Full Text] [Related]
10. Mesoporous Silica-Based Materials with Bactericidal Properties.
Bernardos A; Piacenza E; Sancenón F; Hamidi M; Maleki A; Turner RJ; Martínez-Máñez R
Small; 2019 Jun; 15(24):e1900669. PubMed ID: 31033214
[TBL] [Abstract][Full Text] [Related]
11. Enhanced efficacy and broadening of antibacterial action of drugs via the use of capped mesoporous nanoparticles.
Mas N; Galiana I; Mondragón L; Aznar E; Climent E; Cabedo N; Sancenón F; Murguía JR; Martínez-Máñez R; Marcos MD; Amorós P
Chemistry; 2013 Aug; 19(34):11167-71. PubMed ID: 23839913
[TBL] [Abstract][Full Text] [Related]
12. Co-Delivery of Epirubicin and siRNA Using Functionalized Mesoporous Silica Nanoparticles Enhances In vitro and In vivo Drug Efficacy.
Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Abnous K; Malaekeh-Nikouei B
Curr Drug Deliv; 2016; 13(7):1176-1182. PubMed ID: 26718488
[TBL] [Abstract][Full Text] [Related]
13. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
[TBL] [Abstract][Full Text] [Related]
14. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
[TBL] [Abstract][Full Text] [Related]
15. Peptide-laden mesoporous silica nanoparticles with promoted bioactivity and osteo-differentiation ability for bone tissue engineering.
Luo Z; Deng Y; Zhang R; Wang M; Bai Y; Zhao Q; Lyu Y; Wei J; Wei S
Colloids Surf B Biointerfaces; 2015 Jul; 131():73-82. PubMed ID: 25969416
[TBL] [Abstract][Full Text] [Related]
16. An anti-ROS/hepatic fibrosis drug delivery system based on salvianolic acid B loaded mesoporous silica nanoparticles.
He Q; Zhang J; Chen F; Guo L; Zhu Z; Shi J
Biomaterials; 2010 Oct; 31(30):7785-96. PubMed ID: 20674009
[TBL] [Abstract][Full Text] [Related]
17. Janus silver mesoporous silica nanobullets with synergistic antibacterial functions.
Chang ZM; Wang Z; Lu MM; Shao D; Yue J; Yang D; Li MQ; Dong WF
Colloids Surf B Biointerfaces; 2017 Sep; 157():199-206. PubMed ID: 28595136
[TBL] [Abstract][Full Text] [Related]
18. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.
Tang F; Li L; Chen D
Adv Mater; 2012 Mar; 24(12):1504-34. PubMed ID: 22378538
[TBL] [Abstract][Full Text] [Related]
19. Layer-by-Layer (LBL) Self-Assembled Biohybrid Nanomaterials for Efficient Antibacterial Applications.
Wu Y; Long Y; Li QL; Han S; Ma J; Yang YW; Gao H
ACS Appl Mater Interfaces; 2015 Aug; 7(31):17255-63. PubMed ID: 26192024
[TBL] [Abstract][Full Text] [Related]
20. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
